Business and latest position
1933 Industries is a Nevada-focused cannabis cultivator and producer whose AMA subsidiary sells flower, pre-rolls and concentrates. The CSE lists TGIF as active Tier 2; the issuer also identifies the U.S. OTCID symbol TGIFF.
For the nine months ended April 30, 2026, the issuer reported revenue of C$12.201 million, down 7.12% from C$13.137 million, and gross profit of C$3.278 million, down from C$5.318 million. CIN recomputes gross margin at 26.86%, versus 40.48% a year earlier, a 13.62-point contraction. Reported net income was C$154,092. Third-quarter revenue of C$4.291 million rose 8.80% sequentially but fell 9.28% year over year. The mixed picture is therefore cost-led profitability against weaker sales and materially lower gross margin—not yet evidence of durable growth.
The decisive risk is financing, not the quarter
On December 19, 2025, the company said it could not repay its 2024 unsecured convertible debentures in cash without impairing operations. Conversion was offered at C$0.05 per unit, each comprising one share and one C$0.05 warrant expiring December 31, 2028, with accrued interest settled in shares. By December 30, the issuer reported C$1.035 million converted and C$1.563 million still outstanding. The converted principal alone implies 20.7 million shares plus 20.7 million warrants, before interest shares.
That disclosure makes dilution, refinancing, default and business-continuity outcomes central to valuation. The CSE reports 490,471,657 shares issued and 52,620,270 reserved for issuance, but its page shows no usable last price, bid or ask. CIN therefore withholds a current quote, valuation, target and upside rather than substituting stale market data.
What would change the status
- Verified settlement or refinancing terms for the remaining debenture principal.
- Readable filed financial statements and MD&A sufficient to verify cash, working capital, cash flow and lease obligations.
- Evidence that any quarterly gross-margin improvement is repeatable without sacrificing revenue.
- A contemporaneous, attributable market quote suitable for per-share valuation.
This is a fact-checked initial review, not a full underwrite. Until those gaps close, the appropriate conclusion is NotRated with no verified price target.